Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107051394> ?p ?o ?g. }
- W2107051394 endingPage "1673" @default.
- W2107051394 startingPage "1673" @default.
- W2107051394 abstract "Olodaterol is a novel long-acting β2-agonist with proven ≥24-hour duration of action in preclinical and clinical studies.This randomized, double-blind, placebo-controlled, parallel-group study evaluated the dose response of once-daily (QD) olodaterol based on bronchodilator efficacy, safety, and pharmacokinetics over 4 weeks in Japanese patients with chronic obstructive pulmonary disease (COPD).All eligible patients were randomized to receive 2 µg, 5 µg, or 10 µg of olodaterol or placebo for 4 weeks via the Respimat Soft Mist inhaler. The primary end point was the change from baseline in trough forced expiratory volume in 1 second (FEV1) after 4 weeks of olodaterol treatment. Secondary end points included trough FEV1 after 1 week and 2 weeks of treatment, FEV1 area under the curve from 0 hour to 3 hours (AUC(0-3)), peak FEV1 from 0 hour to 3 hours (peak FEV1), and corresponding forced vital capacity (FVC) responses. Rescue medication use, COPD symptoms, physician global evaluation, pharmacokinetics, and safety were also assessed.A total of 328 patients with COPD were randomized to receive treatment. All olodaterol doses assessed in the study showed statistically significant increases in trough FEV1 compared to placebo at Day 29 (P<0.0001). Mean increases in peak FEV1 and FEV1 AUC(0-3) compared to placebo were also significant (P<0.0001). A clear dose-response relationship was observed across all treatment groups. FVC responses (trough and FVC AUC(0-3)) supported FEV1 outcomes. All doses of olodaterol were well tolerated, and no safety concerns were identified.QD olodaterol demonstrated 24-hour bronchodilator efficacy and was well tolerated in Japanese patients with COPD.ClinicalTrials.gov: NCT00824382." @default.
- W2107051394 created "2016-06-24" @default.
- W2107051394 creator A5007084931 @default.
- W2107051394 creator A5007157113 @default.
- W2107051394 creator A5010344834 @default.
- W2107051394 creator A5014804090 @default.
- W2107051394 creator A5025484018 @default.
- W2107051394 creator A5059718263 @default.
- W2107051394 creator A5078286163 @default.
- W2107051394 date "2015-08-01" @default.
- W2107051394 modified "2023-10-18" @default.
- W2107051394 title "Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease" @default.
- W2107051394 cites W1984207232 @default.
- W2107051394 cites W1997673007 @default.
- W2107051394 cites W2003693083 @default.
- W2107051394 cites W2019445754 @default.
- W2107051394 cites W2038697731 @default.
- W2107051394 cites W2045616259 @default.
- W2107051394 cites W2060873423 @default.
- W2107051394 cites W2066043730 @default.
- W2107051394 cites W2085884784 @default.
- W2107051394 cites W2095049468 @default.
- W2107051394 cites W2112628693 @default.
- W2107051394 cites W2118132357 @default.
- W2107051394 cites W2125078269 @default.
- W2107051394 cites W2139148381 @default.
- W2107051394 cites W2149199480 @default.
- W2107051394 cites W2153810843 @default.
- W2107051394 cites W2160431793 @default.
- W2107051394 cites W2167912256 @default.
- W2107051394 doi "https://doi.org/10.2147/copd.s86002" @default.
- W2107051394 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4548739" @default.
- W2107051394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26316741" @default.
- W2107051394 hasPublicationYear "2015" @default.
- W2107051394 type Work @default.
- W2107051394 sameAs 2107051394 @default.
- W2107051394 citedByCount "4" @default.
- W2107051394 countsByYear W21070513942016 @default.
- W2107051394 countsByYear W21070513942017 @default.
- W2107051394 countsByYear W21070513942019 @default.
- W2107051394 countsByYear W21070513942020 @default.
- W2107051394 crossrefType "journal-article" @default.
- W2107051394 hasAuthorship W2107051394A5007084931 @default.
- W2107051394 hasAuthorship W2107051394A5007157113 @default.
- W2107051394 hasAuthorship W2107051394A5010344834 @default.
- W2107051394 hasAuthorship W2107051394A5014804090 @default.
- W2107051394 hasAuthorship W2107051394A5025484018 @default.
- W2107051394 hasAuthorship W2107051394A5059718263 @default.
- W2107051394 hasAuthorship W2107051394A5078286163 @default.
- W2107051394 hasBestOaLocation W21070513941 @default.
- W2107051394 hasConcept C112705442 @default.
- W2107051394 hasConcept C126322002 @default.
- W2107051394 hasConcept C142724271 @default.
- W2107051394 hasConcept C165637977 @default.
- W2107051394 hasConcept C168563851 @default.
- W2107051394 hasConcept C203092338 @default.
- W2107051394 hasConcept C204787440 @default.
- W2107051394 hasConcept C27081682 @default.
- W2107051394 hasConcept C2776042228 @default.
- W2107051394 hasConcept C2776780178 @default.
- W2107051394 hasConcept C2777714996 @default.
- W2107051394 hasConcept C2780261241 @default.
- W2107051394 hasConcept C2780333948 @default.
- W2107051394 hasConcept C2781018748 @default.
- W2107051394 hasConcept C3018587741 @default.
- W2107051394 hasConcept C42219234 @default.
- W2107051394 hasConcept C55520419 @default.
- W2107051394 hasConcept C71924100 @default.
- W2107051394 hasConcept C76318530 @default.
- W2107051394 hasConceptScore W2107051394C112705442 @default.
- W2107051394 hasConceptScore W2107051394C126322002 @default.
- W2107051394 hasConceptScore W2107051394C142724271 @default.
- W2107051394 hasConceptScore W2107051394C165637977 @default.
- W2107051394 hasConceptScore W2107051394C168563851 @default.
- W2107051394 hasConceptScore W2107051394C203092338 @default.
- W2107051394 hasConceptScore W2107051394C204787440 @default.
- W2107051394 hasConceptScore W2107051394C27081682 @default.
- W2107051394 hasConceptScore W2107051394C2776042228 @default.
- W2107051394 hasConceptScore W2107051394C2776780178 @default.
- W2107051394 hasConceptScore W2107051394C2777714996 @default.
- W2107051394 hasConceptScore W2107051394C2780261241 @default.
- W2107051394 hasConceptScore W2107051394C2780333948 @default.
- W2107051394 hasConceptScore W2107051394C2781018748 @default.
- W2107051394 hasConceptScore W2107051394C3018587741 @default.
- W2107051394 hasConceptScore W2107051394C42219234 @default.
- W2107051394 hasConceptScore W2107051394C55520419 @default.
- W2107051394 hasConceptScore W2107051394C71924100 @default.
- W2107051394 hasConceptScore W2107051394C76318530 @default.
- W2107051394 hasLocation W21070513941 @default.
- W2107051394 hasLocation W21070513942 @default.
- W2107051394 hasLocation W21070513943 @default.
- W2107051394 hasLocation W21070513944 @default.
- W2107051394 hasOpenAccess W2107051394 @default.
- W2107051394 hasPrimaryLocation W21070513941 @default.
- W2107051394 hasRelatedWork W2080948816 @default.
- W2107051394 hasRelatedWork W2109586110 @default.
- W2107051394 hasRelatedWork W2145895600 @default.
- W2107051394 hasRelatedWork W2149893136 @default.